-
Company Profile
![]()
Eat JUST, Inc. – Company Profile
Eat JUST, Inc., known widely as JUST, is a US-based food manufacturing company headquartered in San Francisco that produces plant-based foods that are sold internationally.
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Psilocybin in Binge Eating Disorder Drug Details:Psilocybin (TRP-8802) is under development for the treatment of fibromyalgia,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ketamine in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ketamine in Binge Eating Disorder Drug Details:Ketamine is under development for the treatment of alcohol use...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BMB-101 in Binge Eating Disorder Drug Details:BMA-101 is under development for the treatment of undisclosed seizure...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OMS-527 in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.OMS-527 in Binge Eating Disorder Drug Details:OMS-527 is under development for the treatment of movement disorders...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Binge Eating Disorder Drug Details: Oxytocin (TI-001) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.4979 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1.4979 in Binge Eating Disorder Drug Details: BP-1.4979 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NOE-115 in Binge Eating Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NOE-115 in Binge Eating DisorderDrug Details:NOE-115 is under development for the treatment of atypical depression and...
-
Product Insights
Fresh n’ Lean – Ready-to-Eat Meal Delivery Facility – Nevada
Equip yourself with the essential tools needed to make informed and profitable decisions with our Fresh n' Lean - Ready-to-Eat Meal Delivery Facility - Nevada report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Eat JUST/ Proterra Invest – Plant-Based Protein Production Facility – Central Singapore
Equip yourself with the essential tools needed to make informed and profitable decisions with our Eat JUST/ Proterra Invest - Plant-Based Protein Production Facility - Central Singapore report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
![]()
Just Eat Limited – Company Profile
Just Eat Limited (Just Eat), a part of Just Eat Takeaway.com, is a provider of online food delivery services. The company offers online takeaway ordering services. Its restaurant partners offer various cuisine types and cater for all takeaway occasions including breakfast, lunch and dinner. Just Eat enables its customers to place orders using mobile apps, smart TVs, gaming platforms and social media platforms. It operates in France, Canada, Australia, Denmark, Ireland, Italy, Switzerland, Norway, Spain, New Zealand and the UK....
Add to Basket -
Company Profile
![]()
Just Eat Takeawaycom NV – Company Profile
Just Eat Takeawaycom NV (Just Eat), formerly Takeaway.com NV, is a provider of food delivery services. The company's business includes a platform that connects consumers and restaurants. It offers services through various applications and websites such as Lieferando.de, Bistro.sk, Lieferservice.at, Just Eat, Pyszne.pl, Takeaway.com and Thuisbezorgd.nl. Its platforms allow users a wide range of restaurants, to scroll through or search for a particular restaurant or cuisine and place an order. It collaborates with local restaurants and payment banks across cities...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia) Drug Details: Oxytocin (TI-001) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Migraine
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Migraine Drug Details: Oxytocin (TI-001) is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Obesity Drug Details: Oxytocin (TI-001) is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.4979 in Restless Legs Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1.4979 in Restless Legs Syndrome Drug Details: BP-1.4979 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BMB-101 in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Drug Details:BMA-101 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Seizures
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BMB-101 in Seizures Drug Details:BMA-101 is under development for the treatment of undisclosed seizure disorder, Dravet...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Opium (Opioid) Addiction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BMB-101 in Opium (Opioid) Addiction Drug Details:BMA-101 is under development for the treatment of undisclosed seizure...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMB-101 in Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BMB-101 in Alzheimer's Disease Drug Details:BMA-101 is under development for the treatment of undisclosed seizure disorder,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.